FRONTIER MEDICINES Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for FRONTIER MEDICINES with the United States Patent and Trademark Office. The USPTO has given the FRONTIER MEDICINES trademark a serial number of 90981166. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, September 9, 2024. This trademark is owned by Frontier Medicines Corporation. The FRONTIER MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Small molecule pharmaceuticals for the treatment of cancer

pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer
frontier medicines

General Information

Serial Number90981166
Word MarkFRONTIER MEDICINES
Filing DateThursday, August 13, 2020
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements

Goods and ServicesSmall molecule pharmaceuticals for the treatment of cancer
NOT AVAILABLE"MEDICINES"
Goods and Servicespharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 16, 2020
Primary Code005
First Use Anywhere DateMonday, November 20, 2023
First Use In Commerce DateMonday, November 20, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 16, 2020
Primary Code042
First Use Anywhere DateMonday, September 30, 2019
First Use In Commerce DateMonday, September 30, 2019

Trademark Owner History

Party NameFrontier Medicines Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFrontier Medicines Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, December 15, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 15, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 17, 2020NEW APPLICATION ENTERED
Wednesday, September 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 8, 2020ASSIGNED TO EXAMINER
Wednesday, January 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 4, 2021SUSPENSION LETTER WRITTEN
Friday, June 4, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 15, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 15, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, June 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 4, 2021LETTER OF SUSPENSION E-MAILED
Thursday, June 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 6, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, December 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 15, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, January 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022SOU EXTENSION 1 FILED
Tuesday, September 27, 2022SOU EXTENSION 1 GRANTED
Tuesday, September 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 2 GRANTED
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 2 FILED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 8, 2023SOU EXTENSION 3 FILED
Friday, September 8, 2023SOU EXTENSION 3 GRANTED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 28, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 5, 2024SOU EXTENSION 4 GRANTED
Friday, April 5, 2024SOU EXTENSION 4 FILED
Saturday, April 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 17, 2024USE AMENDMENT FILED
Friday, May 17, 2024DIVISIONAL REQUEST RECEIVED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 21, 2024DIVISIONAL PROCESSING COMPLETE
Friday, May 17, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, May 18, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, September 9, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 9, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 12, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

medicines frontier research development pharmaceutical cancer treatment pharmaceuticals molecule products services small